- 91-7088989654
- harkapharmaceuticals@gmail.com
Triple Power for Comprehensive Glycemic Control
Indications & Mechanism:
This is a prescription medication. The enteric-coated pellets (Rabeprazole) protect the active ingredient from stomach acid so it can be absorbed in the intestine. The sustained-release pellets (Domperidone) release the drug slowly over time.
Composition):
Each hard gelatin capsule contains:
Rabeprazole Sodium IP (as enteric coated pellets): 20 mg
Domperidone IP (as sustained release pellets): 30 mg
Excipients: q.s.
Approved colors are used in capsule shells.
Active Ingredients: Rabeprazole Sodium (20 mg, Enteric Coated) & Domperidone (30 mg, Sustained Release).
Formulation Type: Cap-in-Cap system or multi-particulate system with pellets (enteric and sustained release) inside a hard gelatin shell.
Rabogast-DSR Capsules Treatment of acid-related stomach disorders, such as gastroesophageal reflux disease (GERD) and stomach ulcers, combined with an agent (Domperidone) that aids movement in the stomach to counteract nausea or reflux.The capsule must be swallowed whole to preserve the integrity of the specialized coating and delivery mechanism of the pellets.